UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F | ¨ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | | --- | --- | | | OR | | þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the Fiscal Year Ended March 31, 2021 | | | OR | | ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | ¨ | SHELL COMPANY REPORT PURSUANT TO SECTION 13 ...

Dr.Reddy's Laboratories Ltd (NYSE:RDY) Q4 2021 Earnings Conference Call May 14, 2021 8:00 AM ET Company Participants Amit Agarwal - Head, IR & Director, Finance, FP&A & IR G.V. Prasad - Co-Chairman & MD Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Prakash Agarwal - Axis Capital Limited Damayanti Kerai - HSBC Kunal Dhamesha - Emkay Global Neha Manpuria - JPMorgan Chase & Co. Sameer Baisiwala - Morgan Stanley Nikhil Mathur - AMBIT Capital Ranvir Singh - Sunidhi Securities Shyam Srinivas ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q3 2021 Earnings Conference Call January 29, 2021 7:00 AM ET Company Participants Amit Agarwal - Head-Investor Relations Erez Israeli - Chief Executive Officer Parag Agarwal - Chief Financial Officer Conference Call Participants Shanti Patel - Shanti Patel Investment Rashmi Sancheti - InCred Research Damayanti Kerai - HSBC Securities and Capital Markets Kunal Dhamesha - Emkay Global Financial Services Nithya Balasubramanian - Sanford C. Bernstein Vishal Manchanda ...

Dr.Reddy's Financial Results Q3 FY21 | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|--------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Jan 29, 2021 | Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performanc ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2021 Earnings Conference Call October 28, 2020 8:00 AM ET Company Participants Amit Agarwal - Head-Investor Relations Erez Israeli - Chief Executive Officer Saumen Chakraborty - Chief Financial Officer Conference Call Participants Prakash Agarwal - Axis Capital Damayanti Kerai - HSBC Neha Manpuria - JPMorgan Nithya Balasubramanian - Bernstein Research Tushar Manudhane - Motilal Oswal Sameer Baisiwala - Morgan Stanley Vishal Biraia - Aviva Insurance Surya Patra ...

Dr.Reddy's Financial Results Q1 FY21 | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|--------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Jul 29, 2020 | Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performanc ...

Dr. ReddyÂ's Laboratories Limited (NYSE:RDY) Q4 2020 Earnings Conference Call May 20, 2020 7:45 AM ET Company Participants Amit Agarwal – Head-Investor Relations G.V. Prasad – Co-Chairman and Managing Director Saumen Chakraborty – President and Chief Financial Officer Erez Israeli – Chief Executive Officer Conference Call Participants Yash Gupta – Angel Broking Anubhav Aggarwal – Credit Suisse Neha Manpuria – JPMorgan Prakash Agarwal – Axis Capital Nithya Balasubramanian – Sanford Bernstein Vishal B – Aviva ...

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Q3 2020 Earnings Conference Call January 27, 2020 8:00 AM ET Company Participants Amit Agarwal - IR Saumen Chakraborty - President &^CFO Erez Israeli - CEO Conference Call Participants Aditya Khemka - DSP Investment Managers Prakash Agarwal - Axis Capital Limited Anubhav Aggarwal - Crédit Suisse Neha Manpuria - JPMorgan Chase & Co. Kunal Mehta - Vallum Capital Advisors Sameer Baisiwala - Morgan Stanley Nitin Agarwal - IDFC Securities Limited Surya Patra - PhillipCapit ...

1 | January 27, 2020 | Q3 FY20 Press Meet Q3 FY20 Results January 27, 2020 Classification | PUBLIC Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact, including, but not limited to, those that are ...

38th Annual J. P. Morgan Healthcare Conference 14th January, 2020 Dr. Reddy's Laboratories Limited Hyderabad, India BSE: 500124 | NSE: DRREDDY | NYSE: RDY Dr.Reddy's 00 PROPRIETARY Safe Harbor Statement This presentation contains forward-looking statements and information that involve risks, uncertainties and assumptions. Forward-looking statements are all statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other ...